AMGEN INC et al v. MYLAN INC. et al
Plaintiff: AMGEN INC and AMGEN MANUFACTURING LIMITED
Defendant: MYLAN GMBH, MYLAN PHARMACEUTICALS INC, MYLAN INC. and MYLAN N.V.
Petitioner: HOSPIRA, INC.
Case Number: 2:2017cv01235
Filed: September 22, 2017
Court: US District Court for the Western District of Pennsylvania
Office: Pittsburgh Office
County: XX US, Outside State
Presiding Judge: Mark R Hornak
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Both
RSS RSS Track this Docket
Docket Report

This docket was last retrieved on February 19, 2020. A more recent docket listing may be available from PACER.

Date Filed Document Text
February 19, 2020 Opinion or Order Filing 287 ORDER APPROVING #286 Stipulation Regarding Costs. Signed by Chief Judge Mark R. Hornak on 2/19/20. (bdb)
February 18, 2020 Filing 286 STIPULATION re Costs by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
October 31, 2019 Filing 285 BILL OF COSTS by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC in the amount of $114,738.62 against Amgen Inc. and Amgen Manufacturing Limited. (Attachments: #1 Affidavit of Natasha White) (Soller, Eric)
September 17, 2019 Filing 284 NOTIFICATION of Decision sent to Commissioner of Patents and Trademarks re #283 Order. (Attachments: #1 Judgment) (cjo)
September 17, 2019 Opinion or Order Filing 283 STIPULATION AND ORDER FOR ENTRY OF JUDGMENT OF NON-INFRINGEMENT REGARDING U.S. PATENT NO. 9,643,9971. For the reasons as set forth herein, it is hereby ORDERED as follows: (1) Amgen and Mylan stipulate that, under the reasoning of the Federal Circuit's decision as to the '878 Patent in Amgen Inc. v. Sandoz Inc., Nos. 2018-1551, 2018-1552, Mylan's accused process does not meet the claim limitation "(d) washing the separation matrix; and (e) eluting the protein from the separation matrix" in the '997 Patent, and thus Mylan does not infringe any of the asserted claims of the '997 Patent within the meaning of any provision of 35 U.S.C. 271. (2) Amgen and Mylan stipulate that the Court may enter a judgment of noninfringement in favor of Mylan and against Amgen for the Third and Fourth Counts of Amgen's First Amended and Supplemental Complaint filed on February 7, 2019 (ECF No. #210 ) and the Third Count of Mylan's Answer, Defenses and Counterclaims to First Amended and Supplemental Complaint (ECF No. #220 ) filed on February 28, 2019. (3) Amgen and Mylan stipulate that Mylan's Fourth Count of Mylan's Answer, Defenses and Counterclaims to First Amended and Supplemental Complaint (ECF No. #220 ) filed on February 28, 2019 for a declaratory judgment of invalidity of the '997 Patent will be dismissed without prejudice. (4) Amgen and Mylan stipulate that this Stipulation and and Order for Entry of Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 resolves all pending disputes between the parties before the Court in this action. Signed by Chief Judge Mark R. Hornak on 9/17/19. (bdb)
September 13, 2019 Filing 282 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C) (Baldauf, Kent)
August 22, 2019 Filing 281 NOTIFICATION of Decision sent to Commissioner of Patents and Trademarks re #280 Order Staying Case, Administratively Closing the Case, Set Deadlines. (ept) Modified text on 8/27/2019. (ept)
August 21, 2019 Opinion or Order Filing 280 ORDER. For the reasons as set forth herein, it is hereby ORDERED that: 1. The parties shall promptly confer and file a joint status report if there are any significant developments regarding Amgen's pending petition for rehearing en banc in Amgen Inc. v. Sandoz Inc., Nos. 18-1551, 18- 1552 (Fed. Cir. May 8, 2019). 2. The parties shall file a joint status report on or before September 20, 2019, including as to all relevant proceedings before the Court of Appeals for the Federal Circuit. 3. This civil action will be administratively closed on the docket during the pendency of the STAY, without prejudice to any party. Signed by Chief Judge Mark R. Hornak on 8/21/19. (bdb) Modified text on 8/21/19 to correct grammatical error in docket text. (bdb)
August 9, 2019 Filing 279 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent)
August 4, 2019 Opinion or Order Filing 278 ORDER Directing Physical Meet and Confer and Submission of Joint Status Report. The Court has considered the filings of the parties at #276 , #277 . The Court can advise that counsel have successfully convinced the Court of their mutual capacity to litigate in this Court will unnecessary finger pointing and complexity, and at times, passing compliance with the letter of this Courts Orders, and their willingness to use email rather than direct human communication to accomplish that. No further proof in such regards is required, so counsel is invited to knock it off. The U.S. Court of Appeals has seemingly spoken on matters central to the vitality of further litigation in this Court, in this action, relative to the 707 Patent, but maybe not. So, here is what will actually assist the Court at this juncture. A least one lawyer of a senior level of authority for each party (resident in this District or otherwise as counsel determines) shall meet with one another in the same physical location. They may have with them physically, or via video or teleconference, any support from their own litigation team that the prefer. They shall have with them, physically or via electronic means, any and all client contacts that they believe would need to weigh in on the central issue the Court sees before it at this moment, namely given the precedential decision of the U.S. Court of Appeals for the Federal Circuit in Amgen Inc v. Coherus Biosciences, Inc., 2018-1993 (July 29, 2019), on what basis, if any, can the claims of infringement in this action as to the 707 Patent proceed in good faith. The meet and confer directed by this Order shall occur on or before August 12, 2019, and a JOINT status report shall be filed in such regards on or before August 14, 2019. Signed by Chief Judge Mark R. Hornak on 08/04/2019. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (Hornak, Mark)
August 2, 2019 Filing 277 RESPONSE to #276 Notice,, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent)
July 29, 2019 Filing 276 NOTICE of supplemental authority in support of its Rule 12(c) Renewed Motion for Judgment on the Pleadings Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re #214 Sealed Document, #193 Sealed Document, #191 Motion for Judgment on the Pleadings (Attachments: #1 Exhibit A) (Soller, Eric)
July 25, 2019 Opinion or Order Filing 275 ORDER GRANTING #274 Motion to Withdraw as Attorney. Attorney Rachel A. Smoot terminated. Signed by Chief Judge Mark R. Hornak on 7/25/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
July 24, 2019 Filing 274 Unopposed MOTION to Withdraw as Attorney for Rachel A. Smoot by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
July 9, 2019 Opinion or Order Filing 273 ORDER. It is hereby ORDERED that the abeyance imposed by the #264 Order shall remain in place pending further Order of the Court, to be issued on or around 8/14/19. It may be lifted prior to 8/14/19, or extended past 8/14/19, on motion by either party or sua sponte by the Court for good cause shown. Notwithstanding the abeyance, it is further ORDERED that: the parties shall promptly confer and file a joint status report if the Court of Appeals for the Federal Circuit issues a decision regarding the pending appeal in Amgen Inc. v. Coherus BioSciences, Inc., No. 18-1993 (Fed. Cir. filed May 21, 2018). The parties shall also promptly confer and file a joint status report if there are any significant developments regarding Amgens pending petition for rehearing en banc in Amgen Inc. v. Sandoz Inc., Nos. 18-1551, 18-1552 (Fed. Cir. May 8, 2019). The parties shall file a joint status report on or before 8/7/19, including as to all relevant proceedings before the Court of Appeals for the Federal Circuit. Signed by Chief Judge Mark R. Hornak on 7/9/19. (jad)
July 8, 2019 Filing 272 JOINT STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A) (Baldauf, Kent)
July 2, 2019 Opinion or Order Filing 271 ORDER GRANTING #270 Motion for Paula S. Fritsch to Appear Pro Hac Vice. Signed by Chief Judge Mark R. Hornak on 7/2/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
July 1, 2019 Filing 270 MOTION for attorney Paula S. Fritsch to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5194232) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order, #2 Affidavit) (Fritsch, Paula)
June 28, 2019 Filing 269 REPLY BRIEF re #197 Motion for Summary Judgment (Supplemental) filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
June 21, 2019 Filing 268 SUPPLEMENTAL RESPONSE IN OPPOSITION to Mylan's #197 Motion for Summary Judgment of Non-Infringement re U.S. Patent No. 9,643,997 filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B) (Baldauf, Kent) Modified text on 6/24/2019 to add document linkage. (ept)
June 13, 2019 Opinion or Order Filing 267 ORDER. In light of the provisions of the Court's #264 Order and the representations in Defendants' #266 Notice, it is hereby ORDERED that #258 Motion to Quash Subpoena to Produce Documents is DENIED WITHOUT PREJUDICE, subject to its reassertion should Defendants seek to enforce the relevant subpoenas at a later date. Signed by Chief Judge Mark R. Hornak on 6/13/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
June 13, 2019 Filing 266 Errata re #265 Notice Regarding Third Party Subpoenas by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: Correct spelling error. (Soller, Eric)
June 13, 2019 Filing 265 NOTICE Regarding Third Party Subpoenas by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re #264 Order,, Terminate Motions,, Set Deadlines, (Soller, Eric) Document removed from public view and redocketed at #266 . Modified text on 6/14/2019. (ept)
June 13, 2019 Opinion or Order Filing 264 ORDER. For the reasons as set forth herein, it is hereby ORDERED that #254 Joint Motion for a Status Conference to Resolve the Parties Case Management Disputes is hereby GRANTED IN PART and DENIED IN PART. It is further ORDERED that on or before 7/8/19, the parties shall file a joint status report, including as to all relevant proceedings before the Court of Appeals for the Federal Circuit. Signed by Chief Judge Mark R. Hornak on 6/13/19. (bdb)
June 10, 2019 Filing 263 Minute Entry for proceedings held before Chief Judge Mark R. Hornak: Telephonic Status Conference held on 6/10/19. (Court Reporter: Karen Earley) (jad)
June 6, 2019 Opinion or Order Filing 262 SCHEDULING ORDER. A Telephonic Status Conference is hereby SCHEDULED for 6/10/19 at 1:45 PM before Chief Judge Mark R. Hornak. Counsel shall be prepared to discuss all pending issues. Please refer to #121 AT&T Scheduling Notice and use dial-in no. 1 for this conference. Signed by Chief Judge Mark R. Hornak on 6/6/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
June 4, 2019 Opinion or Order Filing 261 ORDER GRANTING #260 Motion for Extension of Time to File Response. The deadline for Defendants to file a response to Hospira's #258 Motion to Quash is hereby EXTENDED to 6/14/19. Signed by Chief Judge Mark R. Hornak on 6/4/19. (bdb)
June 3, 2019 Filing 260 Unopposed MOTION for Extension of Time to File Response/Reply as to #258 First MOTION to Quash SUBPOENA TO PRODUCE DOCUMENTS by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
May 31, 2019 Filing 259 BRIEF in Support re #258 Motion to Quash SUBPOENA TO PRODUCE DOCUMENTS filed by HOSPIRA, INC.. (Attachments: #1 Affidavit) (Thomas, Emily)
May 31, 2019 Filing 258 First MOTION to Quash SUBPOENA TO PRODUCE DOCUMENTS by HOSPIRA, INC.. (Attachments: #1 Proposed Order) (Thomas, Emily)
May 30, 2019 Filing 257 Proposed Order re #254 Motion for Miscellaneous Relief parties Joint Motion for a Status Conference to Resolve the Parties Case Management Disputes (ECF No. 254) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
May 30, 2019 Opinion or Order Filing 256 ORDER GRANTING #255 Motion to Withdraw as Attorney. Attorney Stephen A. Maniscalco terminated. Signed by Chief Judge Mark R. Hornak on 5/30/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
May 30, 2019 CLERK'S OFFICE QUALITY CONTROL MESSAGE re #254 Motion for a Status Conference to Resolve the Parties Case Management Disputes. ERROR: Proposed Order was not attached. CORRECTION: Attorney is advised to file a proposed order by using the Proposed Order event and linking it to the document in question. (ept)
May 29, 2019 Filing 255 Unopposed MOTION to Withdraw as Attorney (Stephen A. Maniscalco) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
May 29, 2019 Filing 254 Joint MOTION for a Status Conference to Resolve the Parties Case Management Disputes by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2) (Soller, Eric)
May 24, 2019 Opinion or Order Filing 253 ORDER. For the reasons as set forth herein, it is hereby ORDERED that #250 MOTION for Leave to File Documents Under Seal is GRANTED IN PART and DENIED IN PART. Signed by Chief Judge Mark R. Hornak on 5/24/19. (bdb)
May 23, 2019 Opinion or Order Filing 252 ORDER GRANTING #251 Motion for Aaron J. Marks to Appear Pro Hac Vice. Signed by Chief Judge Mark R. Hornak on 5/23/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
May 22, 2019 Filing 251 MOTION for attorney Aaron J. Marks to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5148129) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Marks, Aaron)
May 21, 2019 Filing 250 Unopposed MOTION for Leave to File Documents Under Seal Joint Motion for a Status Conference to Resolve the Parties Case Management Disputes by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric) Modified text on 5/22/2019. (ept)
May 17, 2019 Opinion or Order Filing 249 ORDER GRANTING #248 Motion for John D. Polivick to Appear Pro Hac Vice. Signed by Chief Judge Mark R. Hornak on 5/17/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
May 15, 2019 Filing 248 MOTION for attorney John D. Polivick to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5139693) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit A, #2 Proposed Order) (Polivick, John)
April 15, 2019 Opinion or Order Filing 247 ORDER GRANTING #246 Motion for Extension of Time to Complete Damages-Related Document Production. The deadline for Substantial Completion of Damages-Related Document Production is EXTENDED until 5/3/19. Signed by Chief Judge Mark R. Hornak on 4/15/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
April 12, 2019 Filing 246 Joint MOTION for Extension of Time to Complete Discovery Joint Motion for Extension of Substantial Completion of Damages-Related Document Production by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
April 12, 2019 Opinion or Order Filing 245 ORDER. The Court will defer ruling on #197 Motion for Summary Judgment to permit Plaintiffs to conduct additional discovery. Signed by Chief Judge Mark R. Hornak on 4/12/19. (jad)
April 2, 2019 Filing 244 SEALED DOCUMENT (response to statement of disputed facts) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (ept)
April 2, 2019 Filing 243 SEALED DOCUMENT (Declaration of Eric R Hunt in support of motion for summary judgment of non-infringement) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I) (ept)
April 2, 2019 Filing 242 SEALED DOCUMENT (reply brief in support of summary judgment of non-infringement regardng U.S. Patent No. 9,643,997) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #238 Order on Motion for Leave to File Documents Under Seal. (ept)
March 29, 2019 Filing 241 REDACTION to #197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 Redacted Declaration of Eric R. Hunt In Support of Mylans Motion for Summary Judgment of Non-Infringement by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I) (Soller, Eric)
March 29, 2019 Filing 240 REDACTION to #223 Redacted Document Redacted REDACTED Mylan Response to Statement of Disputed Facts by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
March 29, 2019 Filing 239 REDACTION to #197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 Redacted Reply Brief in Support of Mylans Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
March 25, 2019 Opinion or Order Filing 238 ORDER GRANTING #237 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 3/25/19. (bdb)
March 25, 2019 Filing 237 Unopposed MOTION for Leave to File Documents Under Seal Mylans Reply Brief in Support of its Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
March 14, 2019 Filing 236 SEALED DOCUMENT (Answer to Counterclaims Asserted in its Answer to the First Amended and Supplemental Complaint) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #234 Order on Motion for Leave to File Documents Under Seal. (ept)
March 14, 2019 Filing 235 REDACTION Answer to Defendant Mylan GmbH's Counterclaims Asserted in Answer to First Amended & Supplemental Complaint by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
March 13, 2019 Opinion or Order Filing 234 ORDER GRANTING #233 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 3/13/19. (bdb)
March 13, 2019 Filing 233 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
March 8, 2019 Opinion or Order Filing 232 ORDER GRANTING #231 Motion for Naz E. Wehrli to Appear Pro Hac Vice. Signed by Chief Judge Mark R. Hornak on 3/8/19. (bdb)
March 8, 2019 Filing 231 MOTION for attorney Naz E. Wehrli to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5055738) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Wehrli, Naz)
March 6, 2019 Opinion or Order Filing 230 ORDER GRANTING #229 Motion for Extension of Time to File Response/Reply. It is hereby ORDERED that said Motion is GRANTED, and the deadline for Defendants to file a Reply Brief in Support of their Motion for Summary Judgment of Non- Infringement Regarding U.S. Patent No. 9,643,997 is EXTENDED until March 29, 2019. Signed by Chief Judge Mark R. Hornak on 3/6/19. (bdb)
March 6, 2019 Filing 229 Unopposed MOTION for Extension of Time to File Response/Reply Reply Brief in Support of Defendants Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
March 4, 2019 Filing 228 SEALED DOCUMENT (Jennifer Gordon Declaration in support of Response in Opposition) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F) (ept)
March 4, 2019 Filing 227 SEALED DOCUMENT (Harvey Blanch Declaration in support of Response in Opposition) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 2, #2 Exhibit 3, #3 Exhibit 19, #4 Exhibit 20, #5 Exhibit 21, #6 Exhibit 22) (ept)
March 4, 2019 Filing 226 SEALED DOCUMENT (Response in Opposition to Motion for Summary Judgment) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (ept)
March 4, 2019 Filing 225 SEALED DOCUMENT (Statement of Disputed Facts) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #219 Order on Motion for Leave to File Documents Under Seal. (ept)
March 1, 2019 Filing 224 REDACTION Declaration of Harvey Blanch in Support of Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22) (Baldauf, Kent)
March 1, 2019 Filing 223 REDACTION Statement of Disputed Facts by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
March 1, 2019 Filing 222 REDACTION Declaration of Jennifer Gordon in Support of Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F) (Baldauf, Kent)
March 1, 2019 Filing 221 REDACTION Response in Opposition to Mylan's Motion for Summary Judgment by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
February 28, 2019 Filing 220 ANSWER to #210 Amended Complaint , COUNTERCLAIM against AMGEN INC., AMGEN MANUFACTURING LIMITED by MYLAN PHARMACEUTICALS INC, MYLAN GMBH, MYLAN N.V., MYLAN INC. (Soller, Eric) Modified text on 3/1/2019. (ept)
February 27, 2019 Opinion or Order Filing 219 ORDER GRANTING #218 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 2/27/19. (bdb)
February 27, 2019 Filing 218 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
February 20, 2019 Opinion or Order Filing 217 ORDER GRANTING #216 Motion for Extension of Time to Answer. The deadline for Defendants to file an Answer to Plaintiffs' First Amended and Supplemental Complaint if hereby EXTENDED to 2/28/19. Signed by Chief Judge Mark R. Hornak on 2/20/19. (bdb)
February 19, 2019 Filing 216 Unopposed MOTION for Extension of Time to File Answer re #210 Amended Complaint, filed by AMGEN MANUFACTURING LIMITED, AMGEN INC by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
February 14, 2019 Filing 215 Errata re #213 Redacted Document, Reply Brief in Support of Mylan's Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: correct missing signature and correct to conform to sealed version. (Soller, Eric)
February 14, 2019 Filing 214 SEALED DOCUMENT (Reply Brief in Support of Mylan's Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(C) Regarding U.S. Patent No. 8,273,707) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #212 Order on Motion for Leave to File Documents Under Seal. (ept)
February 14, 2019 CLERK'S OFFICE QUALITY CONTROL MESSAGE re #213 Redacted Document. ERROR: Typed name omitted by s/. CORRECTION: Attorney advised of signature requirements. Attorney to resubmit with signature, using Errata event. (ept)
February 13, 2019 Filing 213 REDACTION to #191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 Reply Brief in support Motion for Judgment on the Pleadings regarding the 707 patent by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 7) (Soller, Eric) Document removed from public view and redocketed at #215 . Modified text on 2/15/2019. (ept)
February 11, 2019 Opinion or Order Filing 212 ORDER GRANTING #211 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 2/11/19. (bdb)
February 11, 2019 Filing 211 Unopposed MOTION for Leave to File Documents Under Seal Seal Mylans Reply Brief in Support of its Renewed Motion for Judgment on the Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 B2 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
February 8, 2019 Update Answer Deadline: Answer due from MYLAN GMBH on 2/21/2019; MYLAN INC. on 2/21/2019; MYLAN N.V. on 2/21/2019; MYLAN PHARMACEUTICALS INC on 2/21/2019 (ept)
February 7, 2019 Filing 210 First AMENDED COMPLAINT against MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC, filed by AMGEN MANUFACTURING LIMITED, AMGEN INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17) (Baldauf, Kent)
February 7, 2019 Opinion or Order Filing 209 ORDER GRANTING #205 Motion for Leave to File an Amended and Supplemental Complaint. Plaintiffs are permitted to file an amended and supplemental complaint on or before 2/15/19. Signed by Chief Judge Mark R. Hornak on 2/7/19. (bdb)
February 7, 2019 Filing 208 SEALED DOCUMENT (Response in Opposition to Mylan's Renewed Motion for Judgment on the Pleadings Pusuant to Rule 12(C) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to 203 Order on Motion for Leave to File Documents Under Seal. (ept)
February 6, 2019 Filing 207 REDACTION Response in Opposition to Mylan's Renewed Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
February 6, 2019 Filing 206 BRIEF in Support re #205 Motion for Leave to File an Amended and Supplemental Complaint filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Baldauf, Kent)
February 6, 2019 Filing 205 Unopposed MOTION for Leave to File an Amended and Supplemental Complaint by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
February 6, 2019 Opinion or Order Filing 204 ORDER APPROVING #196 Proposed Case Management Order. The Court hereby enters the Revised Case Management Scheduling Order as set forth herein. Signed by Chief Judge Mark R. Hornak on 2/6/19. (bdb)
February 4, 2019 Opinion or Order Filing 203 ORDER GRANTING #200 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 2/4/19. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
February 1, 2019 Filing 202 SEALED DOCUMENT (Concise Statement of Material Facts in Support of Motion for Summary Judgment) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #195 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (ept)
February 1, 2019 Filing 201 SEALED DOCUMENT (Brief in Support of Motion for Summary Judgment) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #195 Order on Motion for Leave to File Documents Under Seal. (ept)
February 1, 2019 Filing 200 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
January 30, 2019 Filing 199 REDACTION Brief in Support of Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
January 30, 2019 Filing 198 REDACTION Concise Statement of Material Facts in Support of Motion for Summary Judgment of Non-infringement Regarding US Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Soller, Eric)
January 30, 2019 Filing 197 MOTION for Summary Judgment of non-infringement regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
January 30, 2019 Filing 196 Proposed Case Management Order (Revised) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
January 25, 2019 Opinion or Order Filing 195 ORDER GRANTING #194 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 1/25/19. (bdb)
January 25, 2019 Filing 194 Unopposed MOTION for Leave to File Documents Under Seal Mylans Motion for Summary Judgment of Non-Infringement Regarding U.S. Patent No. 9,643,997 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
January 24, 2019 Filing 193 SEALED DOCUMENT (Brief in Support of Renewed Motion for Judgment on the Pleadings) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #190 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (ept)
January 23, 2019 Filing 192 REDACTION to #191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 Redacted Brief in Support of Renewed MOTION for Judgment on the Pleadings by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (Soller, Eric)
January 23, 2019 Filing 191 Renewed MOTION for Judgment on the Pleadings Pleadings Pursuant to Rule 12(c) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
January 22, 2019 Opinion or Order Filing 190 ORDER GRANTING #189 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 1/22/19. (bdb)
January 22, 2019 Filing 189 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
January 16, 2019 Opinion or Order Filing 188 ORDER. For the reasons as set forth herein, it is hereby ORDERED that the Court's stay of the obligation to engage in discovery is hereby LIFTED and further ORDERED that discovery related to damages shall not be bifurcated from discovery related to liability. It is further ORDERED that the parties shall meet and confer and, on or before January 30, 2019, file a revised proposed case management scheduling that is consistent with this Order. Signed by Chief Judge Mark R. Hornak on 1/16/19. (bdb)
January 14, 2019 Filing 187 SEALED DOCUMENT (Response to Plaintiff's Statement Pursuant to the Court's December 17, 2018 Order) by MYLAN GMBH, MYLAN INC., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #185 Order on Motion for Leave to File, Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4) (ept)
January 11, 2019 Filing 186 REDACTION to #182 Redacted Document, #183 Sealed Document, Response To Plaintiffs' Statement Pursuant to the Court's December 17, 2018 Order by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4) (Soller, Eric)
January 7, 2019 Opinion or Order Filing 185 ORDER GRANTING #184 Motion for Leave to File Response to Amgen's Statement Pursuant to the Court's December 17, 2018 Order and to file the Response Under Seal. Decision to Unseal Document deferred. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Signed by Chief Judge Mark R. Hornak on 1/7/19. (bdb)
January 4, 2019 Filing 184 MOTION for Leave to File Response to Statement regarding Amended Infringement Contentions , MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
January 3, 2019 Filing 183 SEALED DOCUMENT (Statement Pursuant to the Court's December 17, 2018 Order) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #180 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit) (ept)
December 28, 2018 Filing 182 REDACTION Statement Pursuant to the Court's December 17, 2018 Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Baldauf, Kent)
December 28, 2018 Opinion or Order Filing 181 ORDER. On or before 1/8/19, Plaintiffs shall file, with their infringement contentions, a short and concise statement identifying which of their infringement contentions will rely upon facts outside of Defendants' filings with the FDA regarding the accused process. Signed by Chief Judge Mark R. Hornak on 12/28/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
December 20, 2018 Opinion or Order Filing 180 ORDER GRANTING #179 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Chief Judge Mark R. Hornak on 12/20/18. (bdb)
December 20, 2018 Filing 179 Unopposed MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
December 17, 2018 Opinion or Order Filing 178 ORDER. It is hereby ORDERED that Plaintiffs shall file, with their infringement contentions, a short and concise statement identifying which of their infringement contentions will open facts outside of Defendants' filings with the FDA regarding the accused process. It is further ORDERED that all discovery-related deadlines and the obligations to engage in discovery will remain STAYED and held in abeyance pending further Order of the Court. Signed by Chief Judge Mark R. Hornak on 12/17/18. (bdb)
December 14, 2018 Filing 177 STATUS REPORT by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
December 10, 2018 Opinion or Order Filing 176 ORDER GRANTING #175 Joint Motion to set deadlines for Amgen to Serve Amended Infringement Contentions and for Mylan to Serve Amended Invalidity and Non- Infringement Contentions. It is hereby ORDERED that said Motion is GRANTED. Amgen's amended infringement contentions are due on December 21, 2018, and Mylan' s amended invalidity and non-infringement contentions are due on January 11, 2019. Signed by Chief Judge Mark R. Hornak on 12/10/18. (bdb)
December 10, 2018 Filing 175 Joint MOTION to Set the Deadlines for Amgen to Serve Amended Infringement Contentions and for Mylan to Serve Amended Invalidity and Non-Infringement Contentions by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
December 3, 2018 Opinion or Order Filing 174 ORDER GRANTING #173 Joint Motion to Stay the December 7, 2018 Deadline to Move to Amend the Pleadings or Add New Parties. The December 7, 2018 deadline to move to amend the pleadings or add new parties is stayed. The new deadline will be set by further Order of the Court following the submission of the parties' Joint Status Report on December 14, 2018. Signed by Judge Mark R. Hornak on 12/3/18. (bdb)
November 30, 2018 Filing 173 Joint MOTION to Stay the December 7, 2018 Deadline to Move to Amend the Pleadings or Add New Parties by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
November 20, 2018 Opinion or Order Filing 172 ORDER OF COURT as contained herein. The parties are ORDERED to confer and file a Joint Status Report on or before 12/14/18. The Status Report should reflect what each party anticipates the next steps in the litigation will be. Signed by Judge Mark R. Hornak on 11/20/18. (jad)
November 20, 2018 Filing 171 OPINION. Signed by Judge Mark R. Hornak on 11/20/18. (jad)
November 15, 2018 Opinion or Order Filing 170 ORDER. For the reasons as set forth herein, it is hereby ORDERED that #79 Motion for Judgment on the Pleadings Pursuant to Rule 12(c) is hereby DENIED WITHOUT PREJUDICE. It is further ORDERED that all discovery-related deadlines and the obligations to engage in discovery are hereby STAYED and held in abeyance pending further Order. Signed by Judge Mark R. Hornak on 11/15/18. (bdb)
November 6, 2018 Remark: Attorney to disregard the 11/6/2018 quality control message, since attorney John Schwab explained the Notice of Deposition was signed by the plaintiffs' attorney and then filed by the defendants. (ept)
November 6, 2018 CLERK'S OFFICE QUALITY CONTROL MESSAGE re #167 Notice of Video Deposition. ERROR: Signature on document and filer do not match. CORRECTION: Attorney advised of signature requirements. Attorney to resubmit the document using the Errata event. (ept)
November 5, 2018 Filing 169 SEALED DOCUMENT (Responses and Objections to Amgen's Notice of Video Deposition) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #166 Order on Motion for Leave to File Documents Under Seal. (ept)
November 5, 2018 Filing 168 SEALED DOCUMENT (Notice of Video Deposition) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #166 Order on Motion for Leave to File Documents Under Seal. (ept)
November 5, 2018 Filing 167 NOTICE Plaintiffs Notice of Video Deposition by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC re 164 Order, (Attachments: #1 Defendants' Objections) (Schwab, John)
November 5, 2018 Opinion or Order Filing 166 ORDER GRANTING #165 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 11/5/18. (jad)
November 2, 2018 Filing 165 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Schwab, John)
November 1, 2018 Opinion or Order Filing 164 ORDER. In light of the parties' #163 Joint Request for a Status Conference, it is hereby ORDERED that counsel for the Defendants shall file on the docket the disputed Rule 30(b)(6) Notice of Deposition that was referenced in #163 Joint Request, as well as the Defendant's objections to the same. Signed by Judge Mark R. Hornak on 11/1/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
October 30, 2018 Filing 163 NOTICE - Joint Request for a Status Conference by AMGEN INC, AMGEN MANUFACTURING LIMITED (Baldauf, Kent)
October 12, 2018 Opinion or Order Filing 162 ORDER. The Court, having considered #161 Joint Statement of Position, hereby adopts #158 Stipulation Regarding Previously Disputed Claim Term. Signed by Judge Mark R. Hornak on 10/12/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
October 11, 2018 Filing 161 NOTICE - Joint Statement of Position by AMGEN INC, AMGEN MANUFACTURING LIMITED re #159 Order, Set Deadlines, (Baldauf, Kent)
October 10, 2018 Filing 160 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings re Claims Construction held on September 21, 2018 before Judge Mark R. Hornak. Court Reporter Karen M. Earley, Telephone number 412-201-2660. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 10/17/2018. Redaction Request due 10/31/2018. Redacted Transcript Deadline set for 11/13/2018. Release of Transcript Restriction set for 1/8/2019. (kme)
October 2, 2018 Opinion or Order Filing 159 ORDER. The parties are hereby ORDERED to file a joint Statement of Position setting forth the basis for the parties' proposed construction. The Statement of Position shall not exceed five (5) pages and shall include relevant citations to the intrinsic evidence supporting the construction. The Statement of Position shall be filed on or before October 12, 2018. Signed by Judge Mark R. Hornak on 10/2/18. (bdb)
September 28, 2018 Filing 158 STIPULATION Regarding Previously Disputed Claim Term by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
September 24, 2018 Filing 157 Minute Entry for proceedings held before Judge Mark R. Hornak: Claim Construction Hearing held on 9/21/2018. (Court Reporter: Karen Earley) (jad)
September 20, 2018 Opinion or Order Filing 156 ORDER GRANTING #154 Unopposed Motion for Leave to Amend Its Disclosure of Asserted Claims and Infringement Contentions. Plaintiffs are permitted to amend Amgen's Disclosure of Asserted Claims and Infringement Contentions. Signed by Judge Mark R. Hornak on 9/20/18. (jad)
September 20, 2018 Opinion or Order Filing 155 ORDER granting #153 Unopposed Motion to Withdraw Motion for Leave to File Confidential Information Under Seal. Plaintiffs' #149 Motion for Leave to File Confidential Information Under Seal is hereby WITHDRAWN. Signed by Judge Mark R. Hornak on 9/20/18. (jad)
September 20, 2018 Filing 154 Unopposed MOTION for Leave to File / Amend its Disclosure of Asserted Claims and Infringement Contentions by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
September 20, 2018 Filing 153 Unopposed MOTION to Withdraw #149 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
September 18, 2018 Filing 152 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 9/17/18. (Court Reporter: Shirley Hall) (jad)
September 17, 2018 Opinion or Order Filing 151 SCHEDULING ORDER. A Telephonic Status Conference is SCHEDULED for TODAY, September 17, 2018 at 4:00 PM before Judge Mark R. Hornak. Please refer to #121 IMPORTANT NOTICE REGARDING TELEPHONE PROCEEDINGS and use Dial-in No. 2 for this conference. Be prepared to discuss ECF No. #149 . Not more than two (2) lawyers per party should be on the call. Signed by Judge Mark R. Hornak on 9/17/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (jad)
September 17, 2018 Opinion or Order Filing 150 ORDER Regarding Claim Construction Hearing. The Court has received and reviewed the Joint Status Report of the parties, filed September 14, 2018. It is helpful to the Court in understanding the issues which the parties seek to address at the hearing set for 9:30 a.m. September 21, 2018. The Court advises counsel that in terms of the timeblock(s) available to counsel, the Court will conclude the hearing not later than 3:00 p.m., and then will take a mid-morning break of 15 minutes, and a lunch break of at least 45 mintues. Within those parameters, counsel may allocate their presentation time. Signed by Judge Mark R. Hornak on 09/17/2018. (Hornak, Mark)
September 14, 2018 Filing 149 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
September 14, 2018 Filing 148 STATUS REPORT (Joint) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
September 11, 2018 Opinion or Order Filing 147 ORDER. On or before 9/14/18, counsel shall file a Joint Status Report as to what will occur at the Claim Construction Hearing set for 9/21/18 at 9:30 AM, as well as how much time the Court should allot for said hearing. Signed by Judge Mark R. Hornak on 9/11/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
September 7, 2018 Filing 146 STIPULATION Regarding Biocon Ltd. by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
September 4, 2018 Opinion or Order Filing 145 ORDER GRANTING #144 Motion for Eric M. Agovino to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 9/4/18. (jad)
August 30, 2018 Filing 144 MOTION for attorney Eric M. Agovino to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4846057) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Agovino, Eric)
August 28, 2018 Opinion or Order Filing 143 ORDER GRANTING #142 Motion for David J. Ball to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 8/28/18. (jad)
August 27, 2018 Filing 142 MOTION for attorney David J. Ball Jr. to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4841732) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Ball, David)
August 27, 2018 Filing 141 SEALED DOCUMENT (Statement of Position as to Bifurcation or Delay of Damages and Remedial Discovery) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #134 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14) (ept)
August 27, 2018 Filing 140 SEALED DOCUMENT (Exhibit #7 is the main document) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #137 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 8, #2 Exhibit 9, #3 Exhibit 10) (ept)
August 24, 2018 Filing 139 REDACTION Position Statement by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14) (Schwab, John)
August 24, 2018 Filing 138 REDACTION Statement of Position as to Bifurcation/Delay in Damages and Remedial Discovery by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (Baldauf, Kent)
August 22, 2018 Opinion or Order Filing 137 ORDER GRANTING #136 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 8/22/18. (jad)
August 22, 2018 Filing 136 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
August 21, 2018 Filing 135 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings re Telephone Status Conference held on August 3, 2018 before Judge Mark R. Hornak. Court Reporter Juliann A. Kienzle, Telephone number 412.261.6122. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 8/28/2018. Redaction Request due 9/11/2018. Redacted Transcript Deadline set for 9/21/2018. Release of Transcript Restriction set for 11/19/2018. (jak)
August 21, 2018 Opinion or Order Filing 134 ORDER GRANTING #133 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 8/21/18. (bdb)
August 20, 2018 Filing 133 MOTION for Leave to File Documents Under Seal Statement of Position as to Bifurcation Or Delay of Damages and Remedial Discovery by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
August 14, 2018 Filing 132 Sur-Reply Brief on Claim Construction re #130 Sur-Reply Brief, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
August 10, 2018 Opinion or Order Filing 131 ORDER denying as moot #119 Motion Hold Status Conference. The conference having been held, the Motion is dismissed as moot. Signed by Judge Mark R. Hornak on 08/10/2018. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (Hornak, Mark)
August 7, 2018 Filing 130 Sur-Reply Brief on Claim Construction re #114 Reply Brief, filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1) (Soller, Eric)
August 3, 2018 Opinion or Order Filing 129 ORDER. In light of matters discussed during the telephonic status conference held on this date, on or before 8/24/2018, counsel shall file their statements of position as to bifurcation/delay in damages and remedial discovery. Such statements shall be approximately twenty (20) pages or fewer. Signed by Judge Mark R. Hornak on 8/3/2018. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (alb)
August 3, 2018 Filing 128 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 8/3/18. (Court Reporter: Julie Kienzle) (bdb)
July 30, 2018 Opinion or Order Filing 127 ORDER granting #124 Motion for Leave to File File Surreply Brief on Claim Construction. Defendants may file a Surreply Brief on or before 8/7/2018, limited to 10 pages; Plaintiff may file a final Sur-Sureply on or before 8/14/2018, limited to 10 pages. Signed by Judge Mark R. Hornak on 7/30/2018. (kly)
July 27, 2018 Filing 126 REPLY re #124 Motion for Leave to File Surreply Brief filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 7/30/2018 to correct title of event selected. (ept)
July 27, 2018 Filing 125 RESPONSE IN OPPOSITION to #124 Motion for Leave to File, filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
July 24, 2018 Filing 124 MOTION for Leave to File Surreply Brief on Claim Construction by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
July 24, 2018 Filing 123 REPORT of Mediation: Case has not been resolved. The parties are reminded of their obligation to complete the ADR questionnaire and submit within 5 days of the conclusion of the ADR process. The questionnaire can be accessed at www.pawd.uscourts.gov. Click on the ADR icon. Mediation session was held on 5/23/2018. (Soller, Eric)
July 24, 2018 Opinion or Order Filing 122 SCHEDULING ORDER. A Telephonic Status Conference is SCHEDULED for 8/3/18 at 11:30 AM before Judge Mark R. Hornak. Please refer to #121 IMPORTANT NOTICE REGARDING TELEPHONE PROCEEDINGS and use Dial-in No. 1 for this conference. Signed by Judge Mark R. Hornak on 7/24/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (jad)
July 24, 2018 Filing 121 AT&T SCHEDULING NOTICE FOR ALL TELEPHONIC CONFERENCES. Every Telephonic Conference conducted will be via an AT&T call-in number which requires participants to dial-in and provide an access code. When a Telephonic Conference is scheduled you will be instructed to refer back to this Notice and use either Dial-In No. 1 or Dial-In No. 2, both of which are contained in this Notice. This document has a security setting of "Case Participants Only", so only those individuals will have access to view the document. (jad)
July 24, 2018 Opinion or Order Filing 120 ORDER GRANTING #118 Motion for Removal of Document from Public View. The Court Clerk is directed to remove Document No. #116 from public view. Signed by Judge Mark R. Hornak on 7/24/18. (jad)
July 23, 2018 Filing 119 Joint MOTION for a Status Conference by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
July 23, 2018 Filing 118 MOTION for Removal of Document No. 116 from the Court Docket and/or from Public View re #116 Declaration filed by AMGEN MANUFACTURING LIMITED, AMGEN INC by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Wolski, Thomas)
July 21, 2018 Filing 117 DECLARATION re #114 Reply Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Exhibit A) (Wolski, Thomas)
July 20, 2018 Filing 116 DECLARATION re #114 Reply Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Exhibit A) (Wolski, Thomas) Modified on 7/24/2018 to remove document from public view. (ksa)
July 20, 2018 Filing 115 NOTICE - Supplemental Identification of Extrinsic Evidence by AMGEN INC, AMGEN MANUFACTURING LIMITED re #106 Redacted Document (Wolski, Thomas)
July 20, 2018 Filing 114 REPLY BRIEF re #106 Redacted Document - Opening Claim Construction Brief filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1) (Wolski, Thomas)
July 10, 2018 Opinion or Order Filing 113 ORDER GRANTING #112 Motion to Withdraw as Attorney. Attorney Guylaine Hache is terminated. Signed by Judge Mark R. Hornak on 7/10/18. (jad)
July 9, 2018 Filing 112 MOTION to Withdraw as Attorney Attorney Guylaine Hache by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
June 29, 2018 Filing 111 NOTICE Identification of Extrinsic Evidence by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC (Attachments: #1 Exhibit A-Declaration of Jungbauer, #2 Exhibit A to Declaration of Jungbauer, #3 Exhibit B-Declaration of Georgiou, #4 Exhibit A to Declaration of Georgiou, #5 Exhibit B to Declaration of Georgiou, #6 Exhibit C to Declaration of Georgiou, #7 Exhibit 1, #8 Exhibit 2, #9 Exhibit 3, #10 Exhibit 4, #11 Exhibit 5, #12 Exhibit 6, #13 Exhibit 7, #14 Exhibit 8, #15 Exhibit 9, #16 Exhibit 10, #17 Exhibit 11, #18 Exhibit 12, #19 Exhibit 13) (Soller, Eric)
June 29, 2018 Filing 110 RESPONSE to Opening Claim Construction Brief to #106 Redacted Document, filed by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
June 1, 2018 Filing 109 SEALED DOCUMENT by AMGEN INC. This document Sealed pursuant to #105 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 3) (plh)
June 1, 2018 Filing 108 DECLARATION re #106 Redacted Document Opening Claim Construction Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED Affiant: Richard C. Willson. (Attachments: #1 Appendix A) (Baldauf, Kent)
June 1, 2018 Filing 107 NOTICE - Identification of Extrinsic Evidence [LPR 4.3] by AMGEN INC, AMGEN MANUFACTURING LIMITED re #106 Redacted Document (Baldauf, Kent)
June 1, 2018 Filing 106 REDACTION Opening Claim Construction Brief by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1 (Redacted in its Entirety), #2 Exhibit 2, #3 Exhibit 3 (Redacted in its Entirety)) (Baldauf, Kent)
May 31, 2018 Opinion or Order Filing 105 ORDER GRANTING #104 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 5/31/18. (bdb)
May 30, 2018 Filing 104 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
May 17, 2018 Filing 103 Errata re #100 CLAIM Construction Chart -Parties' Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. Reason for Correction: Missing Attachments. (Attachments: #1 Joint Disputed Claim Terms Chart, #2 CV - Rito-Palomares, #3 CV - Willson, #4 CV - Jungbauer, #5 CV - Radtke, #6 CV - Georgiou) (Baldauf, Kent)
May 16, 2018 Filing 102 Appendix to #100 CLAIM Construction Chart by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12) (Soller, Eric) Modified on 5/18/2018. (plh)
May 16, 2018 Filing 101 Appendix of Intrinsic Evidence by AMGEN INC, AMGEN MANUFACTURING LIMITED re #100 CLAIM Construction Chart (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6) (Baldauf, Kent) Modified on 5/17/2018. (plh)
May 16, 2018 Filing 100 CLAIM Construction Chart - Parties' Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Joint Disputed Claim Terms Chart) (Baldauf, Kent) Modified on 6/1/2018. (plh)
May 15, 2018 Opinion or Order Filing 99 ORDER GRANTING #98 Motion for Extension of Time to File. It is hereby ORDERED that the Joint Disputed Claim Terms Chart and Prehearing Statement shall be filed on or before 5/16/2018. Signed by Judge Mark R. Hornak on 5/15/2018. (mao)
May 14, 2018 Filing 98 Joint MOTION for Extension of Time to File Joint Disputed Claim Terms Chart & Prehearing Statement by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
May 11, 2018 Filing 97 SEALED DOCUMENT by MYLAN GMBH, MYLAN INC., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #94 Order on Motion for Leave to File Documents Under Seal (plh)
May 11, 2018 Filing 96 Errata re #95 Redacted Document Reply Brief In Support Of Mylans Motion For Judgment On The Pleadings Pursuant To Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. Reason for Correction: filing lacking signature. (Soller, Eric)
May 11, 2018 Filing 95 REDACTION Reply Brief In Support Of Mylans Motion For Judgment On The Pleadings Pursuant To Rule 12(C) Regarding U.S. Patent No. 8,273,707 by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 5/14/2018. (plh) Document removed from public view SEE ERRATA at Doc. #96 .
May 8, 2018 Opinion or Order Filing 94 ORDER GRANTING #93 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 5/8/18. (jad)
May 7, 2018 Filing 93 Unopposed MOTION for Leave to File Documents Under Seal Reply Brief in Support of its Motion for Judgment on the Pleadings by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
May 3, 2018 Opinion or Order Filing 92 ORDER GRANTING #91 Joint Motion to Amend the Case Management Order. The deadline for the Parties to file a Joint Disputed Claim Terms Chart and Prehearing Statement, in addition to each partys appendix containing a copy of each item of intrinsic evidence cited by the party in the Joint Disputed Claim Terms Chart, is EXTENDED until 5/14/18. Signed by Judge Mark R. Hornak on 5/3/18. (jad)
May 2, 2018 Filing 91 Joint MOTION to Amend/Correct #65 Case Management Order by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
May 2, 2018 Filing 90 Errata re #86 Redacted Document, Response in Opposition to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. Reason for Correction: incomplete redaction of previously filed document. (Attachments: #1 Exhibit 1 (Redacted in its entirety), #2 Exhibit 2 (Redacted in its entirety), #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Baldauf, Kent)
May 1, 2018 Opinion or Order Filing 89 ORDER GRANTING #88 Motion for Extension of Time to File Response/Reply. Defendants shall file a reply to the Defendants' Motion for Judgment on the Pleadings on or before 5/11/2018. Signed by Judge Mark R. Hornak on 05/01/2018. (mao)
April 30, 2018 Filing 88 Unopposed MOTION to Extend Time to May 11, 2018, MOTION for Extension of Time to File Response/Reply as to #86 Redacted Document, #87 Sealed Document by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
April 27, 2018 Filing 87 SEALED DOCUMENT by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #84 Order on Motion for Leave to File Documents Under Seal. (Attachments: #1 Exhibit 1, #2 Exhibit 2) (plh)
April 27, 2018 Filing 86 REDACTION Response in Opposition to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Exhibit 1 (Redacted in its Entirety), #2 Exhibit 2 (Redacted in its Entirety), #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11) (Baldauf, Kent) Modified on 5/2/2018. (plh) Document removed from public view SEE ERRATA at Doc. #90 for corrections.
April 18, 2018 Opinion or Order Filing 85 ORDER GRANTING #82 Motion for Extension of Time to File Response to Defendant's Motion for Judgement. Plaintiff's Response to the motion shall be filed on or before 4/27/2018. Signed by Judge Mark R. Hornak on 04/17/2018. (mao)
April 16, 2018 Opinion or Order Filing 84 ORDER GRANTING #83 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 04/16/2018. (mao)
April 16, 2018 Filing 83 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
April 16, 2018 Filing 82 Unopposed MOTION for Extension of Time to File Response to Defendants' Motion for Judgment on the Pleadings by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
April 6, 2018 Filing 81 SEALED DOCUMENT by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. This document Sealed pursuant to #78 Order on Motion for Leave to File Documents Under Seal, (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (plh)
April 6, 2018 Filing 80 REDACTION to Brief by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10) (Soller, Eric)
April 6, 2018 Filing 79 MOTION for Judgment on the Pleadings Pursuant to Rule 12(c) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
April 4, 2018 Opinion or Order Filing 78 ORDER GRANTING #77 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 04/04/2018. (mao)
April 3, 2018 Filing 77 Unopposed MOTION for Leave to File Documents Under Seal by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
March 14, 2018 Filing 76 STIPULATION selecting ADR process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
March 1, 2018 Opinion or Order Filing 75 ORDER GRANTING #74 Motion for Extension of Time to File Stipulation Selecting ADR. The deadline to file an update Stipulation Selecting ADR is hereby EXTENDED to 3/14/18. Signed by Judge Mark R. Hornak on 3/1/18. (bdb)
February 28, 2018 Filing 74 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Proposed Order) (Soller, Eric)
February 15, 2018 Opinion or Order Filing 73 ORDER GRANTING #72 Motion for Extension of Time to File Updated Stipulation Selecting ADR Process. The deadline is hereby EXTENDED to 2/28/18. Signed by Judge Mark R. Hornak on 2/15/18. (bdb)
February 14, 2018 Filing 72 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
February 8, 2018 Opinion or Order Filing 71 ORDER APPROVING #69 Stipulated Protective Order. The Protective Order as set forth herein is hereby entered by the Court. Signed by Judge Mark R. Hornak on 2/8/18. (bdb)
February 8, 2018 Opinion or Order Filing 70 ORDER GRANTING #68 Motion for Extension of Time to File Stipulation Selecting ADR. It is hereby ORDERED that the deadline for the Parties to file an updated Stipulation Selecting ADR Process is EXTENDED until February 14, 2018. Signed by Judge Mark R. Hornak on 2/8/18. (bdb)
February 7, 2018 Filing 69 STIPULATED PROTECTIVE ORDER by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Baldauf, Kent)
February 7, 2018 Filing 68 Joint MOTION for Extension of Time to File Updated Stipulation Selecting ADR Process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
February 1, 2018 Opinion or Order Filing 67 ORDER APPROVING #66 Joint Status Report. Signed by Judge Mark R. Hornak on 2/1/18. (bdb)
January 31, 2018 Filing 66 JOINT STATUS REPORT by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
January 19, 2018 Opinion or Order Filing 65 ORDER APPROVING #64 Proposed Case Management Order. It Is hereby ORDERED as follows: (1) The parties shall move to amend the pleadings or add new parties by December 7, 2018; (2) The party claiming patent infringement must serve on all parties a Disclosure of Asserted Claims and Infringement Contentions by March 7, 2018; (3) The party claiming non-infringement and/or invalidity must serve on all parties a Disclosure of Non-infringement and/or Invalidity Contentions by March 28, 2018; (4) Each party will simultaneously exchange Proposed Claim Terms and Phrases for Construction by April 11, 2018; 4(a) Each party will simultaneously exchange a preliminary proposed construction ofeach term or phrase by April 25, 2018; (5)The parties shall meet and confer by May 1, 2018 to identify claim terms and phrases that are in dispute, and claim terms and phrases that are not in dispute, and prepare and file aJoint Disputed Claim Terms Chart and Prehearing Statement by May 2, 2018; (6) (6) The parties shall exchange Initial Disclosures per LPR 3.1, including the documents identified below, by February 14, 2018; (7) The parties will submit the name of a proposed mediator to the Court by January 31, 2018; (8) Plaintiff shall file and serve an Opening Claim Construction Brief and anidentification of extrinsic evidence by June 1, 2018; (9) The Opposing Party shall file and serve a response to the Opening Claim ConstructionBrief, an identification of extrinsic evidence and any objections to extrinsic evidence by June 29, 2018; (10) The opening party may serve and file a Reply directly rebutting the opposing party's Response, and any objections to extrinsic evidence by July 20, 2018; (11) The Court will conduct a hearing on the issue of Claim Construction on September 21, 2018 at 9:30 AM; 12) The parties shall complete fact discovery by November 30, 2018, and allinterrogatories, depositions, requests for admissions, and requests for production shall be served within sufficient time to allow responses to be completed prior to the close of discovery; (13) Each party shall make its initial expert witness disclosures, as required under Rule 26, on the issues on which each bears the burden of proof by December 21, 2018; (14) Each party shall make its rebuttal expert witness disclosures, as required under Rule26, on the issues on which the opposing party bears the burden of proof by January 23, 2019; (15) Reply expert witness disclosures are to be made by February 6, 2019; (16) Expert Depositions, if any, shall be completed by March 13, 2019. Signed by Judge Mark R. Hornak on 1/19/18. (bdb)
January 17, 2018 Filing 64 Proposed Case Management Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
January 17, 2018 Filing 63 NOTICE OF FILING OF OFFICIAL TRANSCRIPT of Proceedings held on January 10, 2018 before Judge Mark R. Hornak. Court Reporter Richard Ford, Telephone number (412) 261-0802. The parties have seven (7) calendar days to file with the court a Notice of Intent to Request Redaction of this transcript. If no such Notice is filed, the transcript may be made remotely, electronically available to the public without redaction after 90 calendar days. For redaction purposes, or otherwise, during this 90 day period a copy of the transcript may be purchased from the court reporter or viewed at the clerk's office public terminal. Any Notice of Intent to Request Redaction and Redaction Request must be separately mailed to the court reporter of said proceedings. Notice of Intent for Redaction of Personal Data Identifiers due by 1/24/2018. Redaction Request due 2/7/2018. Redacted Transcript Deadline set for 2/20/2018. Release of Transcript Restriction set for 4/17/2018. (rtf)
January 11, 2018 Opinion or Order Filing 62 ORDER. Counsel shall file on or before January 17, 2018, an updated Proposed Case Management Order inclusive of procedures related to Electronically Stored Information. Counsel shall also file on or before January 31, 2018, an updated Stipulation Selecting ADR Process and a proposed protective order. Signed by Judge Mark R. Hornak on 1/11/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (bdb)
January 11, 2018 Filing 61 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Initial Case Management Conference held on 1/10/18. (Court Reporter: Richard Ford) (jad)
January 10, 2018 Opinion or Order Filing 60 ORDER RESCHEDULING CONFERENCE. The Telephonic Initial Case Management Conference set for 1/10/18 at 4:00 PM is hereby RESCHEDULED for 1/10/18 at 4:30 PM before Judge Mark R. Hornak. The information required to participate can be found at #29 Scheduling Order. Signed by Judge Mark R. Hornak on 1/10/18. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (jad)
January 9, 2018 Opinion or Order Filing 59 ORDER GRANTING #56 Motion for Kimerlin L. Morley to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 1/9/18. (bdb)
January 9, 2018 Opinion or Order Filing 58 ORDER GRANTING #55 Motion for Lois Kwasigroch to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 1/9/18. (bdb)
January 9, 2018 Opinion or Order Filing 57 ORDER GRANTING #54 Motion for Wendy A. Whiteford to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 1/9/18. (bdb)
January 8, 2018 Filing 56 MOTION for attorney Kimberlin L. Morley to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4582025) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Morley, Kimberlin)
January 8, 2018 Filing 55 MOTION for attorney Lois Kwasigroch to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4582008) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Kwasigroch, Lois)
January 8, 2018 Filing 54 MOTION for attorney Wendy A. Whiteford to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4581994) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Whiteford, Wendy )
January 8, 2018 Filing 53 SEALED DOCUMENT (Answer to Counterclaims) by AMGEN INC, AMGEN MANUFACTURING LIMITED. This document Sealed pursuant to #34 Order on Motion for Leave to File Documents Under Seal. (ept)
January 5, 2018 Filing 52 REDACTION Answer to Defendant Mylan GmbH's Counterclaims by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
January 3, 2018 Filing 51 Proposed Initial Scheduling Order by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
January 3, 2018 Filing 50 STIPULATION selecting ADR process by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
January 3, 2018 Filing 49 REPORT of Rule 26(f) Planning Meeting. (Wolski, Thomas)
December 27, 2017 Opinion or Order Filing 48 ORDER GRANTING #41 Motion for Golda Lai to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/27/17. (jad)
December 27, 2017 Opinion or Order Filing 47 ORDER GRANTING #40 Motion for Jacob T. Whitt to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/27/17. (jad)
December 26, 2017 Opinion or Order Filing 46 ORDER GRANTING #39 Motion for Stephen A. Maniscalco to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/26/17. (jad)
December 26, 2017 Opinion or Order Filing 45 ORDER GRANTING #38 Motion for Peter Sandel to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/26/17. (jad)
December 26, 2017 Opinion or Order Filing 44 ORDER GRANTING #37 Motion for Jennifer Gordon to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/26/17. (jad)
December 26, 2017 Opinion or Order Filing 43 ORDER GRANTING #36 Motion for Jennifer H. Wu to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/26/17. (jad)
December 26, 2017 Opinion or Order Filing 42 ORDER GRANTING #35 Motion for Nicholas Groombridge to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 12/26/17. (jad)
December 21, 2017 Filing 41 MOTION for attorney Golda Lai to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569753) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Lai, Golda)
December 21, 2017 Filing 40 MOTION for attorney Jacob T. Whitt to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569752) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Whitt, Jacob)
December 21, 2017 Filing 39 MOTION for attorney Stephen A. Maniscalco to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569750) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Maniscalco, Stephen)
December 21, 2017 Filing 38 MOTION for attorney Peter Sandel to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569749) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Sandel, Peter)
December 21, 2017 Filing 37 MOTION for attorney Jennifer Gordon to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569748) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Gordon, Jennifer)
December 21, 2017 Filing 36 MOTION for attorney Jennifer H. Wu to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569747) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Wu, Jennifer)
December 21, 2017 Filing 35 MOTION for attorney Nicholas Groombridge to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4569746) by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Affidavit, #2 Proposed Order) (Groombridge, Nicholas)
December 19, 2017 Opinion or Order Filing 34 ORDER GRANTING #30 MOTION for Leave to File Documents Under Seal. After receiving notice of the order of court, you must provide the sealed document to the Clerk of Courts both on paper and on disk, in pdf format. In the alternative, you may contact the Intake Section and make arrangements to email the pdf to the Clerk of Courts. The sealed version of the document WILL NOT be docketed by the Clerk of Court until the party electronically files the redacted version of the documents (using Redacted Document event located under Other Documents), unless otherwise ordered by the Court. You would be required to serve the sealed document on counsel using traditional service methods. Decision to Unseal Document deferred. Signed by Judge Mark R. Hornak on 12/19/17. (bdb)
December 19, 2017 Filing 33 Minute Entry for proceedings held before Judge Mark R. Hornak: Telephonic Status Conference held on 12/19/17. (Court Reporter: Richard Ford) (jad)
December 19, 2017 Opinion or Order Filing 32 ORDER RESCHEDULING CONFERENCE. The Telephonic Status Conference set for 12/19/17 at 3:00 PM is hereby RESCHEDULED for 12/19/17 at 3:30 PM before Judge Mark R. Hornak. The information required to participate can be found at #31 Scheduling Order. Signed by Judge Mark R. Hornak on 12/19/17. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (jad)
December 18, 2017 NOTICE to Counsel. Please disregard the "Order Rescheduling Conference" for the Conference set for 12/19/17 at 3:00 PM. The Conference is still scheduled for December 19, 2017 at 3:00 PM. (jad)
December 12, 2017 Opinion or Order Filing 31 ORDER. It is hereby ORDERED that obligation to file a reply to the Counterclaim is hereby held in abeyance pending further Order of Court. It is further ORDERED that a Telephonic Status Conference is hereby SCHEDULED for 12/19/17 at 3:00 PM before Judge Mark R. Hornak. The Court will conduct the call via an AT&T conference number, which requires participants to dial-in and provide an access code. Please see the attached Notice for the information required to participate. Please note you must log-in to ECF and open the Notice from the docket of the case (the document will not open from the link in the e-mail). The document has a security setting of "Case Participants Only", so only those individuals will have access to view the document. Signed by Judge Mark R. Hornak on 12/12/17. (Attachments: #1 Notice (Case Participants Only)) (bdb)
December 8, 2017 Filing 30 MOTION for Leave to File Documents Under Seal by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Proposed Order) (Baldauf, Kent)
November 27, 2017 Opinion or Order Filing 29 ORDER SCHEDULING CONFERENCE. The Telephonic Initial Case Management Conference will be held on 1/10/18 at 4:00 PM. The Conference will be conducted via an AT&T dial-in number, which requires participants to dial-in and provide an access code. To obtain the information required to participate in the conference, please log-in to ECF and open the attached document from the docket of the case (the document will not open from the link in the e-mail). The document has a security setting of "Case Participants Only", so only those individuals will have access to view the document. Rule 26(f) Report and stipulation selecting ADR process due on or before 1/3/18. Signed by Judge Mark R. Hornak on 11/27/17. (Attachments: #1 Notice) (jad)
November 22, 2017 Filing 28 Disclosure Statement identifying none as corporate parent and MYLAN GmbH, Mylan N.V. and Mylan Pharmaceuticals Inc as affiliates, by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric) Modified on 11/24/2017 to add names of affiliates. (ksa)
November 22, 2017 Filing 27 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by MYLAN PHARMACEUTICALS INC, MYLAN N.V., MYLAN GMBH, MYLAN INC.. (Soller, Eric)
October 13, 2017 Opinion or Order Filing 26 ORDER GRANTING #19 Motion for Guylaine Hache to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 25 ORDER GRANTING #18 Motion for Rachel A. Smoot to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 24 ORDER GRANTING #17 Motion for Natasha L. White to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 23 ORDER GRANTING #16 Motion for Heinz J. Salmen to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 22 ORDER GRANTING #15 Motion for Eric R. Hunt to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 21 ORDER GRANTING #14 Motion for Deanne M. Mazzochi to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 13, 2017 Opinion or Order Filing 20 ORDER GRANTING #13 Motion for William A. Rakoczy to Appear Pro Hac Vice. Signed by Judge Mark R. Hornak on 10/13/17. (jad)
October 12, 2017 Filing 19 MOTION for attorney Guylaine Hache to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4494012) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Hache, Guylaine)
October 12, 2017 Filing 18 MOTION for attorney Rachel A. Smoot to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4494003) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Smoot, Rachel)
October 12, 2017 Filing 17 MOTION for attorney Natasha L. White to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493984) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (White, Natasha)
October 12, 2017 Filing 16 MOTION for attorney Heinz J. Salmen to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493969) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Salmen, Heinz)
October 12, 2017 Filing 15 MOTION for attorney Eric R. Hunt to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493933) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Hunt, Eric)
October 12, 2017 Filing 14 MOTION for attorney Deanne M. Mazzochi to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493926) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Mazzochi, Deanne)
October 12, 2017 Filing 13 MOTION for attorney William A. Rakoczy to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-4493879) by MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Attachments: #1 Affidavit, #2 Proposed Order) (Rakoczy, William)
October 4, 2017 Filing 12 WAIVER OF SERVICE Returned Executed by AMGEN INC, AMGEN MANUFACTURING LIMITED. MYLAN GMBH waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN INC. waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN N.V. waiver sent on 9/27/2017, answer due 11/27/2017; MYLAN PHARMACEUTICALS INC waiver sent on 9/27/2017, answer due 11/27/2017. (Baldauf, Kent)
September 27, 2017 Opinion or Order Filing 11 STANDING ORDER ON CIVIL MOTION PRACTICE. Signed by Judge Mark R. Hornak on 9/27/17. (jad)
September 27, 2017 Filing 10 NOTICE that instant civil action has been designated for placement into the United States District Court's Alternative Dispute Resolution program. Parties are directed to fully complete the required 26(f) report, which includes the stipulation of selecting an ADR process. Counsel for plaintiff (or in the case of a removal action, counsel for removing defendant) shall make service of the notice on all parties. (jad)
September 26, 2017 Filing 9 NOTICE of Appearance by John A. Schwab on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Schwab, John)
September 26, 2017 Filing 8 NOTICE of Appearance by William Pietragallo, II on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Pietragallo, William)
September 26, 2017 Filing 7 NOTICE of Appearance by Eric G. Soller on behalf of MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC. (Soller, Eric)
September 26, 2017 Opinion or Order Filing 6 ORDER Declining Assignment of Patent Case, in accordance with Section 1(a)(1)(C) of Public Law 111-349, Pilot Program in Certain District Courts. Signed by Judge David S. Cercone on 9/26/17. (njt)
September 26, 2017 Judge David S. Cercone no longer assigned to case. (gmp)
September 26, 2017 Judge Mark R. Hornak added. (gmp)
September 25, 2017 Filing 5 NOTICE of Appearance by Cecilia R. Dickson on behalf of AMGEN INC, AMGEN MANUFACTURING LIMITED. (Dickson, Cecilia)
September 25, 2017 Filing 4 NOTICE of Appearance by Thomas C. Wolski on behalf of AMGEN INC, AMGEN MANUFACTURING LIMITED. (Wolski, Thomas)
September 25, 2017 Filing 3 PATENT/TRADEMARK DOCUMENTS ISSUED. (Attachments: #1 Complaint, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5) (plh)
September 22, 2017 Filing 2 Disclosure Statement identifying None as corporate parent or other affiliate, by AMGEN INC. Amgen Manufacturing Limited subsidiary of Amgen Inc. (plh)
September 22, 2017 Filing 1 COMPLAINT against MYLAN GMBH, MYLAN INC., MYLAN N.V., MYLAN PHARMACEUTICALS INC (Filing fee, including Administrative fee, $400, receipt number 4472128), filed by AMGEN INC, AMGEN MANUFACTURING LIMITED. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5) (plh)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Pennsylvania Western District Court's Electronic Court Filings (ECF) System

Search for this case: AMGEN INC et al v. MYLAN INC. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MYLAN GMBH
Represented By: William Pietragallo, II
Represented By: Eric G. Soller
Represented By: John A. Schwab
Represented By: Rachel A. Smoot
Represented By: Natasha L. White
Represented By: John David Polivick
Represented By: Eric R. Hunt
Represented By: Guylaine Hache
Represented By: William A. Rakoczy
Represented By: Deanne M. Mazzochi
Represented By: Heinz J. Salmen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MYLAN PHARMACEUTICALS INC
Represented By: William Pietragallo, II
Represented By: Eric G. Soller
Represented By: John A. Schwab
Represented By: Rachel A. Smoot
Represented By: Natasha L. White
Represented By: John David Polivick
Represented By: Eric R. Hunt
Represented By: Guylaine Hache
Represented By: William A. Rakoczy
Represented By: Deanne M. Mazzochi
Represented By: Heinz J. Salmen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MYLAN INC.
Represented By: William Pietragallo, II
Represented By: Eric G. Soller
Represented By: John A. Schwab
Represented By: Rachel A. Smoot
Represented By: Natasha L. White
Represented By: John David Polivick
Represented By: Eric R. Hunt
Represented By: Guylaine Hache
Represented By: William A. Rakoczy
Represented By: Deanne M. Mazzochi
Represented By: Heinz J. Salmen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: MYLAN N.V.
Represented By: William Pietragallo, II
Represented By: Eric G. Soller
Represented By: John A. Schwab
Represented By: Rachel A. Smoot
Represented By: Natasha L. White
Represented By: John David Polivick
Represented By: Eric R. Hunt
Represented By: Guylaine Hache
Represented By: William A. Rakoczy
Represented By: Deanne M. Mazzochi
Represented By: Heinz J. Salmen
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: AMGEN INC
Represented By: Kent E. Baldauf, Jr.
Represented By: Cecilia R. Dickson
Represented By: Thomas C. Wolski
Represented By: Nicholas P. Groombridge
Represented By: Stephen A. Maniscalco
Represented By: Golda Lai
Represented By: Jacob T. Whitt
Represented By: Jennifer H. Wu
Represented By: Lois M. Kwasigroch
Represented By: Eric M Agovino
Represented By: David J. Ball
Represented By: Paula S. Fritsch
Represented By: Kimberlin Morley
Represented By: Peter Sandel
Represented By: Wendy Whiteford
Represented By: Aaron J. Marks
Represented By: Naz E. Wehrli
Represented By: Jennifer Gordon
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: AMGEN MANUFACTURING LIMITED
Represented By: Kent E. Baldauf, Jr.
Represented By: Cecilia R. Dickson
Represented By: Thomas C. Wolski
Represented By: Nicholas P. Groombridge
Represented By: Stephen A. Maniscalco
Represented By: Golda Lai
Represented By: Jacob T. Whitt
Represented By: Jennifer H. Wu
Represented By: Lois M. Kwasigroch
Represented By: Eric M Agovino
Represented By: David J. Ball
Represented By: Paula S. Fritsch
Represented By: Kimberlin Morley
Represented By: Peter Sandel
Represented By: Wendy Whiteford
Represented By: Aaron J. Marks
Represented By: Naz E. Wehrli
Represented By: Jennifer Gordon
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Petitioner: HOSPIRA, INC.
Represented By: Emily B. Thomas
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?